VACS-D Vaginal Arco-ColpoSuspension Device for the treatment of Urinary Incontinence in Women

Summary

Stress Urinary Incontinence (SUI), referring to the involuntary leakage of urine, is a disease that causes embarrassment to sufferers that can lead to isolation, depression, and limitations in working and social life, especially exercise and leisure activities. Our VACS-D will disrupt existing applications for treatment by not only lowering the costs of healthcare making it more accessible by a larger population but also provide a pain free and long lasting solution that will also increase the quality of life as the world population age increases. VACS-D helps a major part of population – women- anywhere in the world. The women’s health is NOT just important for themselves but also from the sustained quality of motherhood as they raise the next generation.

This is a new device with a patent pending (PCT/tr2019/050048) device for the treatment of SUI in women with the power of changing their lives for the better as they age. VACS-D preserves the advantages while eliminating the disadvantages of two surgical methods that were considered the optimum approach in 1965 and 2000. The device enables surgeons to perform surgery via the vagina in a minimally invasive way, with only a single incision and with no need for an artificial implant (mesh), relying instead on native tissue repair. The use of mesh was suspended in the UK in 2018 and in the USA after the reports of FDA in 2008 advising against their use. VACS-D facilitates a new surgical approach that will become the method of choice in the treatment of urinary incontinence in women.

Our multidisciplinary team has extensive clinical and surgical experience in both abdominal colposuspension and midurethral sling operations approaches to the surgical treatment of urinary incontinence. In 2018, the founder, gynecologist and obstetrician Assoc. Prof. Dr. Özgür Yeniel formed a multidisciplinary team after recognizing the need for a new surgical approach.

Resources Show all and search (1)

Unfold all

Fold all

More information & hyperlinks

Web resources:	https://cordis.europa.eu/project/id/954909
Start date:	15-06-2020
End date:	14-06-2022
Total budget - Public funding:	976 250,00 Euro - 683 375,00 Euro

Cordis data

Original description

Stress Urinary Incontinence (SUI), referring to the involuntary leakage of urine, is a disease that causes embarrassment to sufferers that can lead to isolation, depression, and limitations in working and social life, especially exercise and leisure activities. Our VACS-D will disrupt existing applications for treatment by not only lowering the costs of healthcare making it more accessible by a larger population but also provide a pain free and long-lasting solution that will also increase the quality of life as the world population age increases. VACS-D helps a major part of population – women- anywhere in the world. The women’s health is NOT just important for themselves but also from the sustained quality of motherhood as they raise the next generation.

This is a new device with a patent pending (PCT/tr2019/050048) device for the treatment of SUI in women with the power of changing their lives for the better as they age. VACS-D preserves the advantages while eliminating the disadvantages of two surgical methods that were considered the optimum approach in 1965 and 2000.The use of mesh was suspended in the UK in 2018 and in the USA after the reports of FDA in 2008 advising against their use. VACS-D facilitates a new surgical approach that will become the method of choice in the treatment of urinary incontinence in women.

Our multidisciplinary team has extensive clinical and surgical experience in both abdominal colposuspension and midurethral sling operations approaches to the surgical treatment of urinary incontinence. In 2018, the founder, gynecologist, and obstetrician Assoc. Prof. Dr. Özgür Yeniel formed a multidisciplinary team after recognizing the need for a new surgical approach.
.